Optimal treatment allocation and study duration for trials with discrete-time survival endpoints (Q1937208): Difference between revisions

From MaRDI portal
Set OpenAlex properties.
ReferenceBot (talk | contribs)
Changed an Item
Property / cites work
 
Property / cites work: An Introduction to Optimal Designs for Social and Biomedical Research / rank
 
Normal rank
Property / cites work
 
Property / cites work: Sample Size Calculations in Clinical Research / rank
 
Normal rank
Property / cites work
 
Property / cites work: Q3997553 / rank
 
Normal rank
Property / cites work
 
Property / cites work: Q4437934 / rank
 
Normal rank
Property / cites work
 
Property / cites work: On Robust and Efficient Designs for Risk Estimation in Epidemiological Studies / rank
 
Normal rank
Property / cites work
 
Property / cites work: Q5425208 / rank
 
Normal rank
Property / cites work
 
Property / cites work: Cost-effective designs for trials with discrete-time survival endpoints / rank
 
Normal rank
Property / cites work
 
Property / cites work: Sample Sizes for Clinical Trials / rank
 
Normal rank
Property / cites work
 
Property / cites work: Efficiency of Balanced Treatment Allocation for Survival Analysis / rank
 
Normal rank
Property / cites work
 
Property / cites work: Evaluation of Sample Size and Power for Analyses of Survival with Allowance for Nonuniform Patient Entry, Losses to Follow-Up, Noncompliance, and Stratification / rank
 
Normal rank
Property / cites work
 
Property / cites work: Survival Analysis / rank
 
Normal rank
Property / cites work
 
Property / cites work: Q3716094 / rank
 
Normal rank
Property / cites work
 
Property / cites work: Q4792070 / rank
 
Normal rank
Property / cites work
 
Property / cites work: Maximind-optimal designs for binary longitudinal responses / rank
 
Normal rank

Revision as of 05:12, 6 July 2024

scientific article
Language Label Description Also known as
English
Optimal treatment allocation and study duration for trials with discrete-time survival endpoints
scientific article

    Statements

    Optimal treatment allocation and study duration for trials with discrete-time survival endpoints (English)
    0 references
    0 references
    0 references
    28 February 2013
    0 references
    discrete-time longitudinal data
    0 references
    survival analysis
    0 references
    optimal designs
    0 references
    cost function
    0 references
    allocation ratio
    0 references

    Identifiers